Walter Berger

Curriculum Vitae WALTER BERGER Personal details Citizenship: Austria Current address: Center for Cancer Research; Medical University Vienna; A-1090 Vienna, Borschkegasse 8a, Austria; Tel: 0043-1-40160-57555; E-mail: walter.berger@meduniwien.ac.at Website: http://krebsforschung.meduniwien.ac.at/researcher/walter_berger/ Main areas of research Development of novel tumor-targeted therapeutic strategies for solid tumor Mechanisms of therapy resistance against chemotherapy and novel anticancer compounds Genomic alterations in the progression of solid tumors Experience Since 11/2013 Full Professorship for Applied & Experimental Oncology, Medical University Vienna Since 2010 Deputy head of the Institute of Cancer Research Vienna Since 6/2004 Head of the Research Unit “Development of Experimental Cancer Therapeutics” at the Department of Medicine I, Medical University Vienna Since 6/2001 Associate Professor at the Institute of Cancer Research, Medical University Vienna 6/2001 Habilitation in "Applied and Experimental Oncology" at the Medical Faculty, Vienna University 1998/1999 Post Doc stay at the Institute of Oncology, Cambridge University, UK (Head: Bruce Ponder) 1993 - 2001 Post Doc and Assistant professor at the Institute of Tumor Biology/Cancer Research, Dept. Applied and Experimental Oncology, Vienna University Education 1991- 1993 Ph.D. study at the Institute for Tumor Biology/Cancer Research, Dept. Applied and Experimental Oncology 1989 - 1993 Product and project management with Hoechst/Austria Company. Education in project and personnel management 1988 - 2/1989 Diploma Thesis (Master) Institute of Plant Physiology 1983 Study of Biology (Physiology) and German Philology, University of Vienna Teaching Since 1993 Lectures and practical studies for Ph.D and M.D. students Since 1998 Lectures in postgraduate courses on tumor biology and toxicology Since 1998 Supervision of 7 Diploma and 12 Ph.D. as well as 4 M.D. students Prizes and Awards (selection) 2011 Forschungs- und Entwicklungspreis für Innovative Krebsforschung der Gemeinde Wien. 2014 Central European Prize for Innovative Cancer Research Grants (selection) FWF P22072 Novel Thiosemicarbazons as Anticancer Drugs . 2010-2013 FWF L568 Novel Platinum Compounds as Cancer Therapeutics. 2009-2013 FWF P17630 FGF/FGF Signals as Therapeutic Targets in Solid Tumors. 2007-2010 GENAU PLACEBO 2009-2012 FFG Cancer drug delivery with bacterial ghosts 2013-2016 Memberships 1 American Association for Cancer Research 2 Austrian Society for Haematology and Oncology 3 Austrian Society for Neurooncology Key international cooperation partners V. Mathieu, Laboratory of Toxicology, Institute of Pharmacy, Free University of Brussels (ULB), Brussels, Belgium R.D. Süßmuth, Institute of Chemistry, Technical University Berlin, Germany R. Stoika, Institute of Cell Biology, NAS of Ukraine, Lviv 79005, Ukraine Publications 280 original papers in peer reviewed journals; 9 invited reviews; ~14500 citations; H-factor: 63